| 01/03/2019 |
Financement de l’UE : Epigenome maintenance in response to DNA damage |
| 01/01/2019 |
Financement de l’UE (11 M €) : ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND) |
| 20/06/2019 |
Financement de l’UE (12,3 M €) : NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW |
| 18/04/2019 |
Financement de l’UE (122 678 €) : Self-Healing Hydrogels for Material-Assisted Cell therapy in Osteoarthritis |
| 01/01/2019 |
Financement de l’UE (14,2 M €) : Genome, Environment, Microbiome & Metabolome in Autism: an integrated multi-omic systems biology approach to identify biomarkers for personalized treatment and primary prevention of Autism Spectr |
| 01/05/2019 |
Financement de l’UE (146 227 €) : Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging |
| 01/04/2019 |
Financement de l’UE (146 227 €) : Induction of B cell immunity in the lung mucosa |
| 01/04/2019 |
Financement de l’UE (15,3 M €) : Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation |
| 13/08/2019 |
Financement de l’UE (150 000 €) : A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) |
| 30/04/2019 |
Financement de l’UE (150 000 €) : Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis |
| 01/01/2019 |
Financement de l’UE (15 M €) : Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. |
| 01/01/2019 |
Financement de l’UE (15 M €) : Induced pluripotent stem cell-based therapy for spinal regeneration |
| 01/03/2019 |
Financement de l’UE (17,8 M €) : Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts |
| 03/05/2019 |
Financement de l’UE (184 708 €) : Language and Brain Rhythms |
| 27/04/2019 |
Financement de l’UE (184 708 €) : Using PML nuclear body biology to identify potential AML treatment targets |
| 03/05/2019 |
Financement de l’UE (196 708 €) : Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease |
| 01/05/2019 |
Financement de l’UE (196 708 €) : Mechanosensing and Mitral Valve Prolapse: from the Molecular Mechanisms to the Progression of the Disease |
| 03/06/2019 |
Financement de l’UE (196 708 €) : P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis |
| 04/05/2019 |
Financement de l’UE (196 708 €) : REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion. |
| 01/03/2019 |
Financement de l’UE (1 000 000 €) : RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients |
| 17/10/2019 |
Financement de l’UE (1 237 400 €) : Visualizing Death Inducing Protein Complexes |
| 01/01/2019 |
Financement de l’UE (1 497 441 €) : Nociception and sensory nerves as regulators of type 2 immunity and skin inflammation |
| 14/02/2019 |
Financement de l’UE (1 500 000 €) : Regulation of synaptic development and plasticity by molecular pathways linked to human evolution |
| 21/06/2019 |
Financement de l’UE (1 850 000 €) : Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease |
| 12/09/2019 |
Financement de l’UE (1 999 391 €) : Metabolic integration by nutrient SENSing |
| 14/01/2019 |
Financement de l’UE (26,1 M €) : Providing an open collaborative space for digital biology in Europe |
| 01/01/2019 |
Financement de l’UE (2 106 800 €) : African Research and Innovative Initiative for Sickle cell Education: Improving Research Capacity for Service Improvement |
| 28/08/2019 |
Financement de l’UE (2 496 210 €) : Unravelling the secretion machinery for virulence factors in apicomplexan parasites |
| 11/06/2019 |
Financement de l’UE (2 499 969 €) : Targeting endothelial barriers to combat disease |
| 17/10/2019 |
Financement de l’UE (2 499 995 €) : Deconstructing the role of SUMO on chromatin in cell identity and tissue repair |
| 13/08/2019 |
Financement de l’UE (2 672 562 €) : The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance |
| 04/09/2019 |
Financement de l’UE (2 999 999 €) : Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. |
| 01/01/2019 |
Financement de l’UE (3 097 323 €) : Integrating Environment and Health Research: a Vision for the EU |
| 01/01/2019 |
Financement de l’UE (3 316 013 €) : Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics |
| 01/07/2019 |
Financement de l’UE (3 429 217 €) : Antibiotic Distribution and Recovery in Tissue |
| 30/09/2019 |
Financement de l’UE (3 604 780 €) : Non-invasive dynamic neural control by laser-based technology |
| 01/05/2019 |
Financement de l’UE (3 664 174 €) : ENdoThelial macRophage Alliance In Neuroinflammation |
| 01/06/2019 |
Financement de l’UE (3 969 936 €) : AGE-RELATED CHANGES IN HEMATOPOIESIS |
| 13/08/2019 |
Financement de l’UE (3 992 397 €) : Molecular basis of human enhanceropathies |
| 28/08/2019 |
Financement de l’UE (3 993 480 €) : Erythrocytes properties and viability in dependence of flow and extra-cellular environment |
| 01/01/2019 |
Financement de l’UE (3 996 150 €) : FAIRplus |
| 28/08/2019 |
Financement de l’UE (40,3 M €) : Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions |
| 28/08/2019 |
Financement de l’UE (4 017 848 €) : Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery |
| 17/09/2019 |
Financement de l’UE (4 023 617 €) : A nanovaccine Approach for the treatment of Pancreatic Cancer |
| 23/09/2019 |
Financement de l’UE (4 076 578 €) : Secretion, Autophagy and their role in Neurodegeneration |
| 06/09/2019 |
Financement de l’UE (4 088 951 €) : COmplement Regulation and Variations in Opportunistic infectionS |
| 29/08/2019 |
Financement de l’UE (4 099 782 €) : ONCOgenic Receptor Network of Excellence and Training 2.0 |
| 27/11/2019 |
Financement de l’UE (4 822 197 €) : Human Gonad Developmental Cell Atlas |
| 08/11/2019 |
Financement de l’UE (4 948 385 €) : Integrated silicon photonics for Cardiovascular Disease monitoring |
| 01/01/2019 |
Financement de l’UE (55,1 M €) : European Joint Programme on Rare Diseases |
| 03/05/2019 |
Financement de l’UE (57 646 €) : Merkel cell polyomavirus Oncogenic Network |
| 01/01/2019 |
Financement de l’UE (5 499 882 €) : Vaccines and Infectious Diseases in the Ageing PopuLation |
| 01/01/2019 |
Financement de l’UE (5 998 456 €) : Common Infrastructure for National Cohorts in Europe, Canada, and Africa |
| 20/05/2019 |
Financement de l’UE (5 999 886 €) : The regulatory GENomE of SWine and CHicken: functional annotation during development |
| 26/11/2019 |
Financement de l’UE (6 000 000 €) : Comorbid Analysis of Neurodevelopmental Disorders and Epilepsy |
| 27/11/2019 |
Financement de l’UE (6 000 000 €) : Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity |
| 01/01/2019 |
Financement de l’UE (6 104 476 €) : Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach |
| 27/11/2019 |
Financement de l’UE (6 256 759 €) : 3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients |
| 01/03/2019 |
Financement de l’UE (6 700 000 €) : CARdiomyopathy in type 2 DIAbetes mellitus |
| 01/01/2019 |
Financement de l’UE (6 761 834 €) : Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds |
| 01/07/2019 |
Financement de l’UE (6 880 965 €) : Coordination and Harmonisation of National Inititiatives, Infrastructures and Data services in Central and Western Europe |
| 21/05/2019 |
Financement de l’UE (6 999 989 €) : Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs |
| 02/07/2019 |
Financement de l’UE (799 916 €) : STRENGTHENING THE SFAX UNIVERSITY EXPERTISE FOR DIAGNOSIS AND MANAGEMENT OF EPILEPTIC ENCEPHALOPATHIES |
| 27/11/2019 |
Financement de l’UE (8 064 946 €) : Gene Therapy to restore lymphatic flow lymphedema |
| 01/01/2019 |
Financement de l’UE (8 200 000 €) : NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients |
| 01/01/2019 |
Financement de l’UE (8 480 544 €) : A testing bed for the development of high-risk medical devices |
| 01/03/2019 |
Financement de l’UE (9 866 250 €) : Well-Aging and the Tanycytic Control of Health |
